Skip to main content
UniHealth

Doctor search

Diana Lucia Alba, MD

Endocrinology, Diabetes & Metabolism · San Francisco

NPI 1144547456

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
3
1 carrier
Office
1

Offices

1 location

Plans that list them

3 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alba’s office at (415) 353-2350 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A126283 · Current

Licensed to practise in California · since 2013 · expires 2027-06-30 · New York Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
  • American Board of Internal Medicine - Internal Medicine

Medicaid work

$42,761 in 2024

Medicaid paid $42,761 for 354 billed services this clinician did in 2024, up to 24 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Clinic visit/encounter, all-inclusive123$41,950
Return visit (30+ min)127$811
Short return visit (20+ min)12$0
Service92$0
Medicaid work by year
2024354424$42,761
2023364328$46,437
2022310324$40,788
2021429325$76,365
2020144219$24,557
2019362333$64,196
2018535355$115,352
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Clinic visit/encounter, all-inclusive142$46,247
Return visit (30+ min)132$190
Service90$0

2022

Largest Medicaid services in 2022
Clinic visit/encounter, all-inclusive127$40,576
Return visit (30+ min)118$212
Service65$0

2021

Largest Medicaid services in 2021
Clinic visit/encounter, all-inclusive239$76,230
Return visit (30+ min)93$135
Service97$0

2020

Largest Medicaid services in 2020
Clinic visit/encounter, all-inclusive79$24,557
Return visit (30+ min)65$0

2019

Largest Medicaid services in 2019
Clinic visit/encounter, all-inclusive209$64,119
Return visit (30+ min)101$77
Service52$0

2018

Largest Medicaid services in 2018
Clinic visit/encounter, all-inclusive380$115,032
Short return visit (20+ min)102$164
Return visit (30+ min)53$156

Drugs they prescribed that Part D paid

$39,762

Pharmacies billed $39,762 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 158) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.

73 generic and 72 brand-name prescriptions · $39,762 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ozempic16$12,210$763
Basaglar Kwikpen U-10015$3,099$207
Methimazole26$123$5
Glipizide12$118$10
Metformin Hcl Er11$77$7
See all 6 drugs
Every Part D drug this clinician prescribed
Ozempic16$12,210$763
Basaglar Kwikpen U-10015$3,099$207
Methimazole26$123$5
Glipizide12$118$10
Metformin Hcl Er11$77$7
Metformin14$57$4

Year by year

Part D prescribing by year
2024158200% (0)46%$39,762
2023155280% (0)50%$69,237
2022234330% (0)40%$82,479
2021322370% (0)40%$117,847
2020448620% (0)44%$143,939
2019465730% (0)45%$85,689
201841160None41%$77,017
201724837None24%$28,135
2016259760% (0)None$42,650
20159128NoneNone$7,735
201460160% (0)None$3,996
20138425NoneNone$8,130

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Basaglar Kwikpen U-10018$4,412$245
Metformin16$461$29
Methimazole23$144$6

2022: 7 drugs

Part D drugs prescribed in 2022
Lantus Solostar11$4,759$433
Metformin25$442$18
Levothyroxine12$299$25
Metformin Hcl Er18$187$10
Glipizide23$187$8
Methimazole25$122$5
Lisinopril12$54$5

2021: 10 drugs

Part D drugs prescribed in 2021
Trulicity21$28,550$1,360
Jardiance14$10,451$746
Novolin R11$2,582$235
Easy Touch Pen Needle12$414$35
Levothyroxine14$320$23
Metformin44$312$7
Glipizide34$183$5
Methimazole20$182$9
Metformin Hcl Er12$59$5
Lisinopril14$40$3

2020: 15 drugs

Part D drugs prescribed in 2020
Forteo14$51,963$3,712
Novolog Flexpen16$11,182$699
Basaglar Kwikpen U-10011$7,245$659
Androderm11$7,119$647
Jardiance12$6,491$541
Novolin R20$4,696$235
Novolin N15$4,129$275
Levothyroxine78$1,826$23
Cabergoline12$872$73
Methimazole55$572$10
Testosterone Cypionate12$370$31
Glipizide24$164$7
Alendronate26$132$5
Metformin14$124$9
Metformin Hcl Er12$29$2

2019: 15 drugs

Part D drugs prescribed in 2019
Basaglar Kwikpen U-10017$9,299$547
Novolin R19$5,372$283
Novolin N15$4,852$323
Testosterone33$2,535$77
Levothyroxine107$2,300$21
Cabergoline13$2,159$166
Ultra-Fine Nano Pen Needle13$1,341$103
Methimazole56$780$14
Insulin11$543$49
Synthroid15$526$35
Testosterone Cypionate12$371$31
Metformin12$115$10
Alendronate16$98$6
Glipizide17$86$5
Lisinopril13$44$3

2018: 11 drugs

Part D drugs prescribed in 2018
Lantus Solostar14$7,495$535
Novolin R21$5,281$251
Novolin N11$4,410$401
Basaglar Kwikpen U-10012$4,230$353
Levothyroxine70$1,446$21
Ultra-Fine Nano Pen Needle12$1,096$91
Methimazole43$581$14
Insulin11$359$33
Metformin26$157$6
Glipizide17$63$4
Metformin Hcl Er13$42$3

2017: 6 drugs

Part D drugs prescribed in 2017
Androderm16$8,215$513
Dilantin34$1,231$36
Levothyroxine26$549$21
Phenytoin Sodium Extended34$420$12
Zonisamide48$217$5
Sodium Chloride11$143$13

2016: 8 drugs

Part D drugs prescribed in 2016
Forteo11$27,040$2,458
Tamiflu44$7,906$180
Dilantin28$884$32
Levothyroxine22$544$25
Hydrocortisone12$385$32
Calcitriol12$380$32
Phenytoin Sodium Extended28$340$12
Zonisamide52$235$5

2015: 2 drugs

Part D drugs prescribed in 2015
Levothyroxine15$447$30
Zonisamide11$54$5

2014: 1 drug

Part D drugs prescribed in 2014
Metformin14$149$11

2013: 1 drug

Part D drugs prescribed in 2013
Nexium12$4,637$386

Money from drug and device companies

$82 in 2025

Industry payments by year
202511None$82
202111None$23
202011None$14

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPNone$82
1 payment
  • Meals · 2025-12-12 · $82
See the published payment
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-12-12None$82
See earlier years (2021, 2020)

2021: $23

Payments by company in 2021
Novo NordiskOzempic$23
1 payment
  • Meals for Ozempic · 2021-02-06 · $23

2020: $14

Payments by company in 2020
Novo NordiskOzempic$14
1 payment
  • Meals for Ozempic · 2020-08-03 · $14

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
91.9 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1144547456
Licence
CA A126283California A126283: Current · expires 2027-06-30
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RE0101X (207RE0101X)
Mailing address
400 Parnassus Ave Ste 550, San Francisco, CA, 94143
NPI first listed
2010-04-26
NPI last updated
2016-01-21

This is when the NPI record was last certified, not a medical board exam.